921 related articles for article (PubMed ID: 17854363)
1. Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus.
Järvinen TM; Kanninen P; Jeskanen L; Koskenmies S; Panelius J; Hasan T; Ranki A; Saarialho-Kere U
Br J Dermatol; 2007 Nov; 157(5):970-80. PubMed ID: 17854363
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of tissue inhibitor of metalloproteinases-3 in intestinal and cutaneous lesions of graft-versus-host disease.
Salmela MT; Karjalainen-Lindsberg ML; Jeskanen L; Saarialho-Kere U
Mod Pathol; 2003 Feb; 16(2):108-14. PubMed ID: 12591962
[TBL] [Abstract][Full Text] [Related]
3. Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?
Reefman E; de Jong MC; Kuiper H; Jonkman MF; Limburg PC; Kallenberg CG; Bijl M
Arthritis Res Ther; 2006; 8(6):R156. PubMed ID: 17014704
[TBL] [Abstract][Full Text] [Related]
4. UVB-induced leucocyte trafficking in the epidermis of photosensitive lupus erythematosus patients: normal depletion of Langerhans cells.
Janssens AS; Lashley EE; Out-Luiting CJ; Willemze R; Pavel S; de Gruijl FR
Exp Dermatol; 2005 Feb; 14(2):138-42. PubMed ID: 15679584
[TBL] [Abstract][Full Text] [Related]
5. IL-17 in cutaneous lupus erythematosus.
Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis in different cutaneous manifestations of lupus erythematosus.
Baima B; Sticherling M
Br J Dermatol; 2001 May; 144(5):958-66. PubMed ID: 11359381
[TBL] [Abstract][Full Text] [Related]
7. Identification of granzyme B-expressing CD-8-positive T cells in lymphocytic inflammatory infiltrate in cutaneous lupus erythematosus and in dermatomyositis.
Grassi M; Capello F; Bertolino L; Seia Z; Pippione M
Clin Exp Dermatol; 2009 Dec; 34(8):910-4. PubMed ID: 19456762
[TBL] [Abstract][Full Text] [Related]
8. The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis.
Magro CM; Segal JP; Crowson AN; Chadwick P
J Cutan Pathol; 2010 Jun; 37(6):659-71. PubMed ID: 19891658
[TBL] [Abstract][Full Text] [Related]
9. Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings.
Hasan T; Nyberg F; Stephansson E; Puska P; Häkkinen M; Sarna S; Ros AM; Ranki A
Br J Dermatol; 1997 May; 136(5):699-705. PubMed ID: 9205502
[TBL] [Abstract][Full Text] [Related]
10. Peripheral neuropathy in systemic lupus erythematosus: pathomorphological features and distribution pattern of matrix metalloproteinases.
Mawrin C; Brunn A; Röcken C; Schröder JM
Acta Neuropathol; 2003 Apr; 105(4):365-72. PubMed ID: 12624790
[TBL] [Abstract][Full Text] [Related]
11. The CD40/CD40 ligand system in the skin of patients with subacute cutaneous lupus erythematosus.
Caproni M; Torchia D; Antiga E; Giomi B; Mercuri M; Volpi W; Fabbri P
J Rheumatol; 2007 Dec; 34(12):2412-6. PubMed ID: 18050371
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 and apoptosis in discoid lupus erythematosus.
Zamolo G; Coklo M; Santini Dusevic D; Kastelan M; Batinac T; Materljan E; Brumini G
Croat Med J; 2005 Aug; 46(4):678-84. PubMed ID: 16100773
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous manifestations of systemic lupus erythematosus.
Yell JA; Mbuagbaw J; Burge SM
Br J Dermatol; 1996 Sep; 135(3):355-62. PubMed ID: 8949425
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus.
Järvinen TM; Hellquist A; Koskenmies S; Einarsdottir E; Koskinen LL; Jeskanen L; Berglind L; Panelius J; Hasan T; Ranki A; Kere J; Saarialho-Kere U
Exp Dermatol; 2010 Feb; 19(2):123-31. PubMed ID: 19758313
[TBL] [Abstract][Full Text] [Related]
16. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T
Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
[TBL] [Abstract][Full Text] [Related]
17. Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis.
Pablos JL; Santiago B; Galindo M; Carreira PE; Ballestin C; Gomez-Reino JJ
J Pathol; 1999 May; 188(1):63-8. PubMed ID: 10398142
[TBL] [Abstract][Full Text] [Related]
18. Ultraviolet radiation and the role of matrix metalloproteinases in the pathogenesis of ocular surface squamous neoplasia.
Ng J; Coroneo MT; Wakefield D; Di Girolamo N
Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5295-306. PubMed ID: 18641285
[TBL] [Abstract][Full Text] [Related]
19. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
Oh DJ; Martin JL; Williams AJ; Peck RE; Pokorny C; Russell P; Birk DE; Rhee DJ
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):953-63. PubMed ID: 16505029
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the human lens: implications for cortical cataract formation.
Sachdev NH; Di Girolamo N; Nolan TM; McCluskey PJ; Wakefield D; Coroneo MT
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4075-82. PubMed ID: 15505058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
